Evidence map›Paper›PMID 40056187›Full record

ArticleJournal of neurology2025

Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.

Maximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, Özlem Parlak, Ulrike Weiland, Christine Herrmann, Joachim Schuster, Axel Freischmidt, Kathrin Müller, Reiner Siebert and 19 more

Abstract readPublished Erratum
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Maximilian WiesenfarthDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany. maximilian.wiesenfarth@rku.de.ORCID http://orcid.org/0009-0004-0187-5973
Yalda Forouhideh-WiesenfarthDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Zeynep ElmasDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Özlem ParlakDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Ulrike WeilandDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Christine HerrmannDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Joachim SchusterDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Axel FreischmidtDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Kathrin MüllerInstitute of Human Genetics, Ulm University and Ulm University Medical Center, 89081, Ulm, Germany.
Reiner SiebertInstitute of Human Genetics, Ulm University and Ulm University Medical Center, 89081, Ulm, Germany.
Kornelia GüntherDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Elke FröhlichDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Antje KnehrDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Tatiana SimakDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Franziska BachhuberDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Martin RegensburgerDepartment of Molecular Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Susanne PetriDepartment of Neurology, Hannover Medical School, 30625, Hannover, Germany.
Thomas KlopstockDepartment of Neurology with Friedrich-Baur-Institute, LMU University Hospital, LMU Munich, 80336, Munich, Germany.
Peter ReilichDepartment of Neurology with Friedrich-Baur-Institute, LMU University Hospital, LMU Munich, 80336, Munich, Germany.
Florian SchöberlDepartment of Neurology with Friedrich-Baur-Institute, LMU University Hospital, LMU Munich, 80336, Munich, Germany.
Peggy SchumannAmbulanzpartner Soziotechnologie GmbH, 13353, Berlin, Germany.
Peter KörtvélyessyDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 13353, Berlin, Germany.
Thomas MeyerDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 13353, Berlin, Germany.
Wolfgang P RufDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Simon WitzelDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Hayrettin TumaniDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
David BrennerDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Johannes DorstDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
Albert C LudolphDepartment of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40056187
PMCPMC11890349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.